Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recommendations on the Diagnosis and Treatment of Tuberculosis Infection: SEPAR/SEIMC/Spanish Ministry of Health Consensus Statement.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026
Same author

The Troll Is Weakened but Not yet Defeated: An Update on Cytomegalovirus Management in Transplantation From the International CMV Symposium 2025.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

De Novo Cancer in Liver Transplant Patients With Human Immunodeficiency Virus Infection: A Multicenter Nationwide Cohort Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Rifampicin-resistant tuberculosis in Spain.

ERJ open research·2026
Same author

Recommendations on the Diagnosis and Treatment of Tuberculosis Infection: SEPAR/SEIMC/Spanish Ministry of Health Consensus Statement.

Archivos de bronconeumologia·2026
Same author

Impact of a bundle intervention to improve the prognosis of KPC-producing Klebsiella pneumoniae infection.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Related Experiment Video

Updated: May 22, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Tuberculosis in solid organ transplant patients.

Antonio Doblas1, Fernando Alcaide, Natividad Benito

  • 1Department of Internal Medicine, Hospital de Alta Resolución Valle del Guadiato, Peñarroya-Pueblonuevo, Córdoba, Spain. antoniodoblasdelgado@yahoo.es

Enfermedades Infecciosas Y Microbiologia Clinica
|May 1, 2012
PubMed
Summary

Tuberculosis poses significant risks for solid organ transplant recipients due to diagnostic challenges and drug toxicity. Managing this opportunistic infection requires careful consideration of drug interactions and treatment protocols.

Related Experiment Videos

Last Updated: May 22, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

Area of Science:

  • Infectious Diseases
  • Transplantation Medicine
  • Pharmacology

Background:

  • Tuberculosis (TB) is a serious opportunistic infection in solid organ transplant (SOT) patients.
  • SOT recipients face high morbidity and mortality from TB, often due to delayed diagnosis and drug toxicity.
  • Managing TB in SOT patients presents unique challenges, including drug interactions and toxicity concerns.

Purpose of the Study:

  • To provide an updated understanding of tuberculosis management in solid organ transplant patients.
  • To highlight the diagnostic difficulties and treatment challenges associated with TB in this population.
  • To review current knowledge on drug interactions and toxicity relevant to TB treatment in SOT recipients.

Main Methods:

  • Review of current literature on tuberculosis in solid organ transplant patients.
  • Analysis of diagnostic challenges and treatment strategies.
  • Discussion of drug interactions between antitubercular and immunosuppressive medications.
  • Evaluation of antitubercular drug toxicity, particularly in liver transplant recipients.
  • Assessment of guidelines for treating latent tuberculous infection.

Main Results:

  • Diagnostic difficulties frequently lead to delayed TB treatment initiation in SOT patients.
  • Significant drug interactions exist between antitubercular and immunosuppressant drugs.
  • Antitubercular drugs carry a high risk of toxicity, especially in liver transplant recipients.
  • Clear indications for treating latent TB infection in SOT patients are lacking.

Conclusions:

  • Tuberculosis management in solid organ transplant patients remains complex.
  • Addressing diagnostic delays and drug toxicity is crucial for improving outcomes.
  • Further research and clear guidelines are needed for latent TB infection treatment in SOT recipients.